A Case of Pre-Existing Pregnancy During an In-Vitro Fertilization Cycle
Poh Ting Lim1, Jerry Kok Yen Chan2, Melissa D Tharmalingam2
1Division of Obstetrics and Gynecology, KK Women's and Children's Hospital, Singapore.
Journal of Medical Cases
|September 16, 2021
Summary
Elevated serum progesterone in in-vitro fertilization (IVF) cycles may indicate early pregnancy. This case highlights the importance of considering pre-existing pregnancy when no oocytes are retrieved despite adequate response.
Area of Science:
- Reproductive Endocrinology
- In-Vitro Fertilization (IVF)
- Early Pregnancy Detection
Background:
- Serum progesterone monitoring before oocyte retrieval is standard in IVF to optimize embryo transfer.
- Elevated progesterone levels can negatively impact IVF success rates.
- Normal progesterone levels may warrant investigation for alternative explanations, including early pregnancy.
Observation:
- A 37-year-old patient underwent controlled ovarian hyperstimulation in an IVF cycle.
- Despite adequate follicular response, no oocytes were retrieved during oocyte retrieval.
- Her serum progesterone level on the trigger injection day was 57.8 nmol/L.
Findings:
- The patient had an undetected early pregnancy at the time of the IVF cycle.
- A pregnancy of unknown location was diagnosed three weeks post-oocyte retrieval.
- The patient was successfully treated with systemic methotrexate.
Implications:
- This case underscores the necessity of considering early pregnancy in patients undergoing IVF, especially with unexpected outcomes like failed oocyte retrieval.
- Clinicians should be vigilant for pregnancy of unknown location when progesterone levels are incongruent with IVF cycle response.
- Accurate early pregnancy diagnosis is crucial to prevent unnecessary or potentially harmful IVF interventions and ensure appropriate management.
Related Concept Videos
In Vitro Fertilization
537
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
537
Fertilization
74.9K
During fertilization, an egg and sperm cell fuse to create a new diploid structure. In humans, the process occurs once the egg has been released from the ovary, and travels into the fallopian tubes. The process requires several key steps: 1) sperm present in the genital tract must locate the egg; 2) once there, sperm need to release enzymes to help them burrow through the protective zona pellucida of the egg; and 3) the membranes of a single sperm cell and egg must fuse, with the sperm...
74.9K
Meiosis II
187.3K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
187.3K
Teratogenicity
3.1K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.1K
Ovarian Cycle
2.3K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
2.3K
Infertility in Females
2.4K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
2.4K


